Have a personal or library account? Click to login
Considerations Using Harmaline for a Primate Model of Tremor Cover

Considerations Using Harmaline for a Primate Model of Tremor

Tremor and Other Hyperkinetic Movements
Volume 11 (2021): Issue 1
By: Edward M. Bello,  Madeline Blumenfeld,  Joan Dao,  Jordan D. S. Krieg,  Lucius K. Wilmerding and  Matthew D. Johnson  
Open Access
|Sep 2021

References

  1. 1William Langston J. MPTP and parkinson’s disease. Trends in Neurosciences. 1985 Jan 1; 8: 79–83. DOI: 10.1016/0166-2236(85)90031-1
    Back to article
  2. 2Byl NN. A primate genesis model of focal dystonia and repetitive strain injury: I. Learning-induced dedifferentiation of the representation of the hand in the primary somatosensory cortex in adult monkeys. Neurology. 1996; 47(2): 508–20. DOI: 10.1212/WNL.47.2.508
    Back to article
  3. 3Yang S-H, Cheng P-H, Banta H, Piotrowska-Nitsche K, Yang J-J, Cheng ECH, et al. Towards a transgenic model of Huntington’s disease in a non-human primate. Nature. 2008 Jun; 453(7197): 921–4. DOI: 10.1038/nature06975
    Back to article
  4. 4Haubenberger D, Hallett M. Essential Tremor. New England Journal of Medicine. 2018 May 10; 378(19): 1802–10. DOI: 10.1056/NEJMcp1707928
    Back to article
  5. 5van der Stouwe AMM, Elting JW, van der Hoeven JH, van Laar T, Leenders KL, Maurits NM, et al. How typical are ‘typical’ tremor characteristics? Sensitivity and specificity of five tremor phenomena. Parkinsonism & Related Disorders. 2016 Sep 1; 30: 23–8. DOI: 10.1016/j.parkreldis.2016.06.008
    Back to article
  6. 6Miwa H. Rodent models of tremor. Cerebellum. 2007 Mar 1; 6(1): 66–72. DOI: 10.1080/14734220601016080
    Back to article
  7. 7Elble RJ. Animal models of action tremor. Mov Disord. 1998; 13(Suppl 3): 35–9. DOI: 10.1002/mds.870131306
    Back to article
  8. 8Wilms H, Sievers J, Deuschl G. Animal models of tremor. Movement disorders : official journal of the Movement Disorder Society. 1999 Jul; 14(4): 557–71. DOI: 10.1002/1531-8257(199907)14:4>;557::AID-MDS1004<3.0.CO;2-G
    Back to article
  9. 9Kuo S-H, Louis ED, Faust PL, Handforth A, Chang S, Avlar B, et al. Current Opinions and Consensus for Studying Tremor in Animal Models. Cerebellum. 2019 Dec 1; 18(6): 1036–63. DOI: 10.1007/s12311-019-01037-1
    Back to article
  10. 10Connor JD, Rossi GV, Baker WW. Analysis of the tremor induced by injection of cholinergic agents into the caudate nucleus. International Journal of Neuropharmacology. 1966; 5: 207–16. DOI: 10.1016/0028-3908(66)90025-6
    Back to article
  11. 11LeDoux M. Harmaline Tremor. In: Animal Models of Movement Disorders. Amseterdam; Boston: Elsevier Academic Press. 2005; 361–8. DOI: 10.1016/B978-012088382-0/50032-3
    Back to article
  12. 12Rappaport MS, Gentry RT, Schneider DR, Dole VP. Ethanol effects on harmaline-induced tremor and increase of cerebellar cyclic GMP. Life Sciences. 1984 Jan 2; 34(1): 49–56. DOI: 10.1016/0024-3205(84)90329-1
    Back to article
  13. 13Benazzouz A, Gross C, Féger J, Boraud T, Bioulac B. Reversal of Rigidity and Improvement in Motor Performance by Subthalamic High-frequency Stimulation in MPTP-treated Monkeys. European Journal of Neuroscience. 1993; 5(4): 382–9. DOI: 10.1111/j.1460-9568.1993.tb00505.x
    Back to article
  14. 14Burns RS, Chiueh CC, Markey SP, Ebert MH, Jacobowitz DM, Kopin IJ. A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. PNAS. 1983 Jul 1; 80(14): 4546–50. DOI: 10.1073/pnas.80.14.4546
    Back to article
  15. 15Chiueh CC, Burns RS, Markey SP, Jacobowitz DM, Kopin IJ III. Primate model of parkinsonism: Selective lesion of nigrostriatal neurons by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine produces an extrapyramidal syndrome in rhesus monkeys. Life Sci. 1985 Jan 21; 36(3): 213–8. DOI: 10.1016/0024-3205(85)90061-X
    Back to article
  16. 16Johannessen JN, Chiueh CC, Bacon JP, Garrick NA, Burns RS, Weise VK, et al. Effects of l-Methyl-4-Phenyl-l,2,3,6-Tetrahydropyridine in the Dog: Effect of Pargyline Pretreatment. Journal of Neurochemistry. 1989; 53(2): 582–9. DOI: 10.1111/j.1471-4159.1989.tb07373.x
    Back to article
  17. 17Schneider JS, Yuwiler A, Markham CH. Production of a Parkinson-like syndrome in the cat with N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): Behavior, histology, and biochemistry. Experimental Neurology. 1986 Feb 1; 91(2): 293–307. DOI: 10.1016/0014-4886(86)90070-1
    Back to article
  18. 18Cheng MM, Tang G, Kuo S-H. Harmaline-Induced Tremor in Mice: Videotape Documentation and Open Questions About the Model. Tremor Other Hyperkinet Mov (N Y) [Internet]. 2013 Dec 9 [cited 2020 Dec 30]; 3. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3863988/. DOI: 10.5334/tohm.139
    Back to article
  19. 19Milner TE, Cadoret G, Lessard L, Smith AM. EMG analysis of harmaline-induced tremor in normal and three strains of mutant mice with Purkinje cell degeneration and the role of the inferior olive. J Neurophysiol. 1995 Jun; 73(6): 2568–77. DOI: 10.1152/jn.1995.73.6.2568
    Back to article
  20. 20Lee J, Chang S. Altered Primary Motor Cortex Neuronal Activity in a Rat Model of Harmaline-Induced Tremor During Thalamic Deep Brain Stimulation. Front Cell Neurosci [Internet]. 2019 Oct 15 [cited 2019 Nov 20];13. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6803555/. DOI: 10.3389/fncel.2019.00448
    Back to article
  21. 21Stanford JA, Fowler SC. At low doses, harmaline increases forelimb tremor in the rat. Neuroscience Letters. 1998 Jan 23; 241(1): 41–4. DOI: 10.1016/S0304-3940(97)00974-9
    Back to article
  22. 22Yamazaki M, Tanaka C, Takaori S. Significance of central noradrenergic system on harmaline induced tremor. Pharmacology Biochemistry and Behavior. 1979 Mar 1; 10(3): 421–7. DOI: 10.1016/0091-3057(79)90207-7
    Back to article
  23. 23Lamarre Y, Mercier LA. Neurophysiological studies of harmaline-induced tremor in the cat. Canadian journal of physiology and pharmacology. 1971 Dec; 49(12): 1049–58. DOI: 10.1139/y71-149
    Back to article
  24. 24Lee J, Kim I, Lee J, Knight E, Cheng L, Kang SI, et al. Development of Harmaline-induced Tremor in a Swine Model. Tremor and other hyperkinetic movements (New York, NY). 2018; 8: 532–532. DOI: 10.5334/tohm.406
    Back to article
  25. 25Martin FC, Le AT, Handforth A. Harmaline-induced tremor as a potential preclinical screening method for essential tremor medications. Movement Disord. 2005 Mar; 20(3): 298–305. DOI: 10.1002/mds.20331
    Back to article
  26. 26Battista AF, Nakatani S, Goldstein M, Anagnoste B. Effect of harmaline in monkeys with central nervous system lesions. Experimental Neurology. 1970 Sep 1; 28(3): 513–24. DOI: 10.1016/0014-4886(70)90189-5
    Back to article
  27. 27Larochelle L, Bedard P, Boucher R, Poirier LJ. The rubro-olivo-cerebello-rubral loop and postural tremor in the monkey. Journal of the Neurological Sciences. 1970 Jul 1; 11(1): 53–64. DOI: 10.1016/0022-510X(70)90040-7
    Back to article
  28. 28Ohye C, Bouchard R, Larochelle L, Bédard P, Boucher R, Raphy B, et al. Effect of dorsal rhizotomy on postural tremor in the monkey. Exp Brain Res. 1970; 10(2): 140–50. DOI: 10.1007/BF00234727
    Back to article
  29. 29Poirier LJ, Sourkes TL, Bouvier G, Boucher R, Carabin S. Striatal amines, experimental tremor and the effect of harmaline in the monkey. Brain : a journal of neurology. 1966 Mar; 89(1): 37–52. DOI: 10.1093/brain/89.1.37
    Back to article
  30. 30Poirier LJ, Bouvier G, Bedard P, Boucher R, Larochells L, Olivier A, et al. Essai sur les circuits neuronaux impliques dans le tremblement postural et l’hypokinesie. Rev Neurol (Paris). 1969; 120(1): 15–40.
    Back to article
  31. 31Gauthier GM, Marchetti E, Pellet J. Cerebellar control of vestibulo-ocular reflex (VOR) studied with injection of harmaline in the trained baboon. Archives Italiennes de Biologie. 1983; 121(1): 19–36.
    Back to article
  32. 32Marchetti E, Gauthier G, Pellet J. Cerebellar Control of Eye-Movements Studied with Injection of Harmaline in the Trained Baboon. Arch Ital Biol. 1983; 121(1): 1–17.
    Back to article
  33. 33Bello EM, Agnesi F, Xiao Y, Dao J, Johnson MD. Frequency-dependent spike-pattern changes in motor cortex during thalamic deep brain stimulation. Journal of Neurophysiology. 2020 Sep 23; 124(5): 1518–29. DOI: 10.1152/jn.00198.2020
    Back to article
  34. 34Xiao Y, Agnesi F, Bello EM, Zhang S, Vitek JL, Johnson MD. Deep brain stimulation induces sparse distributions of locally modulated neuronal activity. Scientific Reports [Internet]. 2018 Dec; 8(1). Available from: http://www.nature.com/articles/s41598-018-20428-8. DOI: 10.1038/s41598-018-20428-8
    Back to article
  35. 35Ruebel O, Tritt A, Dichter B, Braun T, Cain N, Clack N, et al. NWB:N 2.0: An Accessible Data Standard for Neurophysiology. 2019 Jan 17 [cited 2020 Dec 13]; Available from: https://escholarship.org/uc/item/8582b6x9. DOI: 10.1101/523035
    Back to article
  36. 36Gemba H, Sasaki K, Yoneda Y, Hashimoto S, Mizuno N. Tremor in the monkey with a cerebellar lesion. Experimental neurology. 1980 Jul; 69(1): 173–82. DOI: 10.1016/0014-4886(80)90152-1
    Back to article
  37. 37Llinas R, Yarom Y. Oscillatory properties of guinea-pig inferior olivary neurones and their pharmacological modulation: an in vitro study. J Physiol. 1986 Jul; 376: 163–82. DOI: 10.1113/jphysiol.1986.sp016147
    Back to article
  38. 38Zutt R, Elting JW, Tijssen MAJ. Chapter 9 – Tremor and myoclonus. In: Levin KH, Chauvel P, editors. Handbook of Clinical Neurology [Internet]. Elsevier; 2019 [cited 2020 Oct 30]. 149–65. (Clinical Neurophysiology: Diseases and Disorders; vol. 161). Available from: http://www.sciencedirect.com/science/article/pii/B9780444641427000461. DOI: 10.1016/B978-0-444-64142-7.00046-1
    Back to article
  39. 39Bekar L, Libionka W, Tian G-F, Xu Q, Torres A, Wang X, et al. Adenosine is crucial for deep brain stimulation-mediated attenuation of tremor. Nature medicine. 2008 Jan; 14(1): 75–80. DOI: 10.1038/nm1693
    Back to article
  40. 40Fowler SC, McKerchar TL, Zarcone TJ. Response dynamics: measurements of the force and rhythm of motor responses in laboratory animals. In: Animal models of movement disorders. 1st ed. Amsterdam; Boston: Elsevier Academic Press. 2005; 73–100. DOI: 10.1016/B978-012088382-0/50007-4
    Back to article
  41. 41Fowler SC, Zarcone TJ, Chen R, Taylor MD, Wright DE. Low grip strength, impaired tongue force and hyperactivity induced by overexpression of neurotrophin-3 in mouse skeletal muscle. International Journal of Developmental Neuroscience. 2002 Jun 1; 20(3): 303–8. DOI: 10.1016/S0736-5748(02)00010-2
    Back to article
  42. 42Wang G, Fowler SC. Concurrent quantification of tremor and depression of locomotor activity induced in rats by harmaline and physostigmine. Psychopharmacology. 2001 Nov 1; 158(3): 273–80. DOI: 10.1007/s002130100882
    Back to article
  43. 43Ho BT, Edward Fritchie G, Idänpään-Heikkilä JE, Wayne Tansey L, McIsaac WM. [3H]Harmaline distribution in monkey brain; pharmacological and autoradiographic study. Brain Research. 1970 Sep 16; 22(3): 397–401. DOI: 10.1016/0006-8993(70)90481-6
    Back to article
  44. 44Mahmoudian M, Jalipour H, Salehian Dardashti P. Toxicity of Peganum harmala: Review and a Case Report. 3. 2002 Apr 1; 1(1): 1–0.
    Back to article
  45. 45Villablanca J, Riobó F. Electroencephalographic and behavioral effects of harmaline in intact cats and in cats with chronic mesencephalic transection. Psychopharmacologia. 1970 Jan 1; 17(4): 302–13. DOI: 10.1007/BF00404235
    Back to article
  46. 46Louis ED, Lenka A. The Olivary Hypothesis of Essential Tremor: Time to Lay this Model to Rest? Tremor Other Hyperkinet Mov (N Y) [Internet]. 2017 Jul 13 [cited 2021 May 14]; 7. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618117/. DOI: 10.5334/tohm.380
    Back to article
  47. 47Pennes HH, Hoch PH. Psychotomimetics, clinical and theoretical considerations: harmine, Win-2299 and nalline. Am J Psychiatry. 1957 Apr; 113(10): 887–92. DOI: 10.1176/ajp.113.10.887
    Back to article
  48. 48Slotkin TA, DiStefano V, Au WYW. Blood Levels and Urinary Excretion of Harmine and Its Metabolites in Man and Rats. J Pharmacol Exp Ther. 1970 May 1; 173(1): 26–30.
    Back to article
DOI: https://doi.org/10.5334/tohm.634 | Journal eISSN: 2160-8288
Journal RSS Feed
Language: English
Submitted on: May 14, 2021
Accepted on: Aug 25, 2021
Published on: Sep 13, 2021
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
tremor,
harmaline,
preclinical model,
non-human primate,
accelerometer

© 2021 Edward M. Bello, Madeline Blumenfeld, Joan Dao, Jordan D. S. Krieg, Lucius K. Wilmerding, Matthew D. Johnson, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 11 (2021): Issue 1Next article